Sign up for the QMED & MD+DI Daily newsletter.
Sponsored By
Allergan Acquisition Fights ObesityAllergan Acquisition Fights Obesity
Adding to its portfolio of weight control products, Allergan Inc. (Irvine, CA) has bought EndoArt SA, a Swiss company that focuses on treating morbid obesity. EndoArt manufactures EASYBAND, a remote-controlled gastric band that is implanted in the upper stomach and adjusted based on weight loss needs via a control unit. Allergan, which purchased EndoArt for $97 million, will be seeking FDA approval of the wireless device after it completes clinical studies in the United States.
February 23, 2007
1 Min Read
.svg?width=850&auto=webp&quality=95&format=jpg&disable=upscale "Allergan Acquisition Fights Obesity")
The company already makes LAP-BAND, the only adjustable implant device for individual weight loss approved in the country. Allergan also manufactures a nonsurgical intragastic balloon that is used outside the United States to treat obesity. According to an article in the Red Herring, Johnson & Johnson will be providing some competition, as it's slated to enter the U.S. market with its Swedish Adjustable Gastric Band this year. Its subsidary Ethicon Endo-Surgery has already made the product available in Europe.
You May Also Like
.png?width=300&auto=webp&quality=80&disable=upscale)
.png?width=300&auto=webp&quality=80&disable=upscale)
.png?width=300&auto=webp&quality=80&disable=upscale)